Pancreatic Cancer Research

ResearcherHeidelberg UniversityNo recent work listed

Michael A. Keese

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7787-3131; OpenAlex author ID A5087315762. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. Last author DOI 10.3390/ijms241713530↗
  2. Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads. Last author DOI 10.1016/j.pan.2012.11.305↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Felix Rückert · 1 shared paper, 2023 · strength 0.17
  2. Christoph Reißfelder · 1 shared paper, 2023 · strength 0.17
  3. Feng Guo · 1 shared paper, 2023 · strength 0.17
  4. Vugar Yagublu · 1 shared paper, 2013 · strength 0.04
  5. Matthias J. Löhr · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.